Douglas Insights
The key players in the market currently include Scientific Genomics Inc, Thermo Fischer Scientific, Blue Heron, TeselaGen, GenScript, DNA2.0, Integrated DNA Technologies, Eurofins Scientific, Inc, Editas Medicine Inc., among others.
Isle of man, Oct. 10, 2022 (GLOBE NEWSWIRE) -- The Douglas Insights Search Engine is the worlds first engine that offers comparative market analysis, and it has also recently addedSynthetic Biologyto the database. Market analysts, industry specialists, business personnel, and all relevant entities can make use of this comparative engine to identify the drivers, hindrances, obstacles, limitations, and opportunities for growth in each market. With the help of these insights, future market predictions can also be made. The engine users will be able to sort the relevant information by price, publication date, publisher rating, and table of contents, all of which will make access easier.
Synthetic biology refers to using lab-generated technology to help with biological processes and concerns. Synthetic biology refers to the development of testing kits, vaccines, treatments, and infectious diseases. In fact, synthetic biology played a key element in the Covid-19 pandemic as well. The development of the vaccine was accelerated, and new technology was used for vaccine development, showing how Synthetic integral biology was to the ordeal. Other than medical applications, the industry also helps to further develop the food and agriculture industry through genetic engineering and genome synthesis and helps industries by manufacturing Biofuels, biomaterials, industrial enzymes, and other useful products.
There are many drivers in the field of synthetic biology due to its need in the current era. For example, the wide range of applications of synthetic biology is one of the main factors driving the market growth. Synthetic biology can be applied to various industries, including food and agriculture, industrial work, and of course, many medical applications. The medical applications of synthetic biology will be driving the market the most.
Story continues
Compare the report and make your decision - https://douglasinsights.com/synthetic-biology-market
Need a Custom Report? Not to worry, you can create your own project using our service.
Create you own custom project here- https://douglasinsights.com/projects
Other than that, the market will also continue to grow due to the increased funding of research and development projects by many governments. This funding will fuel research into the industry and allow for more applications of synthetic biology to arise moving forward. One example is biofuels, which will be much more common and necessary for the environment in the coming years as well.
However, there are still quite a few factors that are currently restricting market growth. These include biosafety, ethical, and security concerns regarding biological safety. One example of ethical and safety concerns is the possible intentional or unintentional introduction of synthetic organisms into ecosystems which can cause great disruption. These organisms can also breed with naturally occurring microorganisms, causing hybrid species to be released and hampering the environment as we know it. In fact, this is one of the ways in which antibiotic-resistant microorganisms can also be generated.
The largest market share of synthetic biology goes to North America. This is because it is the hub of most of the market's key players and has the most funding for medically forward projects. Other than that, Europe and the Asia Pacific also have large shares in the market and will use them for further development in the arena.
The key players in the market currently include Scientific Genomics Inc, Thermo Fischer Scientific, Blue Heron, TeselaGen, GenScript, DNA2.0, Integrated DNA Technologies, Eurofins Scientific, Inc, Editas Medicine Inc., among others. These players are working on further developments while also adding to the industry at present.
The tools currently used in the synthetic biology market include enzymes, Oligonucleotides, synthetic DNA, Synthetic cells, cloning technology, xeno nucleic acids, and chassis organisms. The technology being used in the market at present includes gene synthesis and genetic engineering, cloning, bioinformatics, sequencing, nanotechnology, micro fluids, among many others.
Key questions answered in this report
COVID 19 impact analysis on global Synthetic Biology industry.
What are the current market trends and dynamics in the Synthetic Biology market and valuable opportunities for emerging players?
What is driving Synthetic Biology market?
What are the key challenges to market growth?
Which segment accounts for the fastest CAGR during the forecast period?
Which product type segment holds a larger market share and why?
Are low and middle-income economies investing in the Synthetic Biology market?
Key growth pockets on the basis of regions, types, applications, and end-users
What is the market trend and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Unique data points of this report
Statistics on Synthetic Biology and spending worldwide
Recent trends across different regions in terms of adoption of Synthetic Biology across industries
Notable developments going on in the industry
Attractive investment proposition for segments as well as geography
Comparative scenario for all the segments for years 2018 (actual) and 2031 (forecast)
Compare the report and make your decision - https://douglasinsights.com/synthetic-biology-market
Need a Custom Report? Not to worry, you can create your own project using our service.
Create you own custom project here- https://douglasinsights.com/projects
Follow Douglas Insights For More Industry Updates- @LinkedIn&Twitter
Explore More Press Releases -https://douglasinsights.com/press
Similar Market Research Report Comparisons:
Computational Biology Market: The computational biology market is growing rapidly due to the increasing demand for personalized medicine and drug development, and the need for early diagnosis of diseases. Computational biology is the study of biological processes using computational techniques.
Industrial Microbiology Market: Industrial microbiology is the study of microorganisms that are useful in the production of food, chemicals, pharmaceuticals, and other industrial products. The demand for industrial microbiology is driven by the need for efficient and eco-friendly production processes, as well as the need for improved product quality.
Automated Microbiology Market: This market is primarily driven by the increasing demand for rapid and accurate detection of microorganisms in food, water, and pharmaceuticals. The rising incidents of foodborne illnesses and the increasing stringent regulations regarding food safety are also fueling the growth of this market.
Pharmaceutical Rapid Microbiology Testing Market: The increasing demand for rapid microbiology testing in the pharmaceutical industry is driven by the need for faster and more accurate results. Rapid microbiology testing helps in reducing the time required for product release, which is a major advantage for pharmaceutical companies.
About Douglas Insights-
Douglas Insights UK limited is the first company to provide comparison of market research reports by Table of content, price, ratings and number of pages. We understand the value of time. Productivity and efficiency are possible when you take prompt and assured decisions. With our advanced algorithm, filters, and comparison engine, you can compare your preferred reports simultaneously, based on publisher rating, published date, price, and list of tables. Our data portal enables you to find and review the reports from several publishers. You can evaluate numerous reports on the same screen and select the sample for your best match.
See the original post here:
Synthetic Biology Market is Expected to Report a CAGR of ~21% from 2021 to 2029: Industry Size, Growth & Forecast at Douglas Insights - Yahoo...
- Principles of Genetic Engineering - PMC - National Center for ... - March 28th, 2024
- Historic Overview of Genetic Engineering Technologies for Human Gene ... - March 28th, 2024
- 20.3: Genetic Engineering - Biology LibreTexts - December 10th, 2023
- Genetically modified organism - Wikipedia - November 16th, 2023
- Genetic engineering - DNA Modification, Cloning, Gene Splicing - November 16th, 2023
- 18 Human Genetic Engineering - Clemson University - April 7th, 2023
- Pros and Cons of Genetic Engineering - Benefits and Risks - April 7th, 2023
- Genetic Engineering - Meaning, Applications, Advantages and Challenges ... - March 12th, 2023
- Genetic Engineering Principles of Biology - December 27th, 2022
- Engineering the Perfect Baby | MIT Technology Review - December 27th, 2022
- What is CRISPR? | Live Science - November 24th, 2022
- To modify or not to modify? Genetic Modification and Gene Editing - A divergence by the UK - Lexology - October 13th, 2022
- DNA and the impossibility of research in isolation - Morning Star Online - October 13th, 2022
- Genome editing technologies: final conclusions of the re-examination of Article 13 of the Oviedo Convention - Council of Europe - October 13th, 2022
- Approval, Commercialization Highlighted at Cell & Gene Meeting on the Mesa - Genetic Engineering & Biotechnology News - October 13th, 2022
- Dissatisfaction and New Articulations - Discovery Institute - October 13th, 2022
- In 'The Cultivar Series,' Uli Westphal Gets to the Root of Crop Diversity and Agricultural Modification - Colossal - October 13th, 2022
- Genomic Research Aids in the Effort to Understand How Best to Treat Deadly Infections Caused by a Fungus - UMass News and Media Relations - October 13th, 2022
- Farmers, consumers will embrace GMOs if they understand them - The Standard - October 13th, 2022
- Emily Whitten: The limits of science and human intelligence - WORLD News Group - October 13th, 2022
- Behind this Nobel prize is a very human story: theres a bit of Neanderthal in all of us - The Guardian - October 13th, 2022
- Earth materials in technology The National - The National - October 13th, 2022
- Gene therapy brings hope to people with sickle cell, HIV - Monitor - October 13th, 2022
- Eligo Bioscience Receives FDA Orphan Drug Designation (ODD) and Rare Pediatric Disease (RPD) Designation for EB003 for the Prevention of Hemolytic... - October 13th, 2022
- Skin Grafting, Cryopreservation, and Diseases: A Review Article - Cureus - October 13th, 2022
- Cultured meat could help solve the climate crisis. Heres what it will take to move it from the lab to the dinner table - Fortune - October 13th, 2022
- Ignore scary messages: We've never had it so good & that's not manure - West Side Index & Gustine Press-Standard - October 13th, 2022
- Global Phosphoramidite Market Report 2022: Increasing Synthetic Nucleotide Applications in Therapeutics Drives Growth - ResearchAndMarkets.com -... - October 13th, 2022
- Enzymes Market worth $16.9 billion by 2027 - Exclusive Report by MarketsandMarkets - Yahoo Finance - October 4th, 2022
- Experts Sound Alarm Over 'Growing Threat' of Genetically Engineered Trees - Common Dreams - October 4th, 2022
- Scientists are manipulating the DNA of mosquitoes to fight the spread of malaria - Euronews - October 4th, 2022
- Smile Coffee Werks upgraded its coffee beans to Fair Trade and USDA Organic - Vending Market Watch - October 4th, 2022
- COVID mRNA Jabs and Testing Kicked Off This Industry of Drug Development: Here's What You Need to Know - The Epoch Times - October 4th, 2022
- 22nd Century Group (Nasdaq: XXII) Expands VLN Distributor Network with the Addition of Specialty Distrib - Benzinga - October 4th, 2022
- Researchers are seeking to develop spuds that resist harmful nematodes - FreshPlaza.com - October 4th, 2022
- Synthetic biology has the power to cure and kill. How will we use it? - Big Think - September 25th, 2022
- SPECIAL REPORT: Bioengineered food labeling: 'They kind of shot in the middle and missed every constituency' - FoodNavigator-USA.com - September 25th, 2022
- Yeast-Fermented Chemo: Now We Can Brew Anything - Medscape - September 25th, 2022
- September 23, 2022: The Integrity of Marius Mason WFHB - WFHB News - September 25th, 2022
- 2 Risky Cathie Wood Growth Stocks to Buy and Hold for 5 Years - The Motley Fool - September 25th, 2022
- Bananas threatened by devastating fungus given temporary resistance - New Scientist - September 25th, 2022
- 'What Hath God Wrought' - Today, Luddites Are Concerned About Weedkillers Like They Once Were The Telegraph - Science 2.0 - September 25th, 2022
- Children should be educated about oral health and hygiene - Star of Mysore - September 25th, 2022
- Id rather eat an actual burger: why plant-based meats sizzle fizzled in the US - The Guardian - September 25th, 2022
- Health Tech startups are booming. These 11 VC investors are behind some of the hottest deals - Fortune - September 25th, 2022
- Last Chance This Fall to Tell the NOSB To Uphold Organic Integrity - Beyond Pesticides - September 25th, 2022
- Cambodian PM begins official visit to Cuba - Khmer Times - September 25th, 2022
- Researchers develop method to prevent spread of melanoma to brain - Xinhua - September 25th, 2022
- I'm allergic to the cat, what can I do? - Surinenglish.com - September 25th, 2022
- Researchers Propose a New Way of Regulating Engineered Crops - Modern Farmer - September 16th, 2022
- Purple Tomato is first genetically engineered plant to be deregulated through USDA's new regulatory status review process - Lexology - September 16th, 2022
- Genetically Modified Feed Market to Hit $135 billion by 2030, says Global Market Insights Inc. - Yahoo Finance - September 16th, 2022
- Africa, GMOs and Western Interests - DW (English) - September 16th, 2022
- The science behind the oil supply breakdown in 'Last Light' - Syfy - September 16th, 2022
- Inside the controversial plan to bring extinct animals back from the dead - The Independent - September 16th, 2022
- Star Trek Actor Says Their Trek Hero Is Just Like Their Marvel Character - Giant Freakin Robot - September 16th, 2022
- Scientists closer to making blood stem cells in the lab - Cosmos - September 16th, 2022
- Oncolytic Cancer Therapies Market is expected to grow at a CAGR of 33% by 2032 | DelveInsight - Digital Journal - September 16th, 2022
- Don't call it waste - it can be turned into hydrogen if you handle it right - Innovation Origins - September 16th, 2022
- Can gene editing ease the cost of living crisis? - The Grocer - September 8th, 2022
- Gene editing could revive the American chestnut tree and help fight climate change but familiar anti-biotechonology activist critics will have none... - September 8th, 2022
- Colossal to de-extinct the Tasmanian tiger. Is it a safe thing to do? - Cape Cod Times - September 8th, 2022
- The Future of Nanotech, the World's Tiniest Industry - Entrepreneur - September 8th, 2022
- Viewpoint: The 'natural food' sham 'Effective communication on the ethics of science may be hindered by appeals to naturalness' - Genetic Literacy... - September 8th, 2022
- Toray says it has developed the worlds first 100% bio-based adipic acid - Biofuels Digest - September 8th, 2022
- Chinese scientists claim to have engineered the world's first mouse with fully reprogrammed genes - Interesting Engineering - August 30th, 2022
- Century Therapeutics Receives Study May Proceed Notification from FDA for CNTY-101, the First Allogeneic Cell Therapy Product Candidate Engineered to... - August 30th, 2022
- Living Carbon: The startup setting down roots from 9 to 5 | Greenbiz - GreenBiz - August 30th, 2022
- Novavax Nuvaxovid COVID-19 Vaccine Granted Expanded Conditional Marketing Authorization in the United Kingdom for Use in Adolescents Aged 12 Through... - August 30th, 2022
- Genetics in fiction - Wikipedia - August 14th, 2022
- Weeds superpower could help feed the planet - Freethink - August 14th, 2022
- POSEIDA THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) - Marketscreener.com - August 14th, 2022
- Novartis Confirms Deaths of Two Patients Treated with Gene Therapy Zolgensma - Genetic Engineering & Biotechnology News - August 14th, 2022
- LETTER TO THE EDITOR: Lessons from 1984 | Letters To Editor | carolinacoastonline.com - Carolinacoastonline - August 14th, 2022
- How Arkeon Biotechnologies is turning CO2 into food: 'Excuse my language, but this is next-level cool' - FoodNavigator.com - August 14th, 2022
- Synlogic Announces Synthetic Biotic for Gout Developed in Partnership with Ginkgo Bioworks - PR Newswire - August 14th, 2022
- THE SAD STORY OF THE REJECTION OF SCIENCE - Sp Supplements - DAWN.COM - DAWN.com - August 14th, 2022
- Global Genome Editing Technologies market is projected to grow at a CAGR of 15.96% by 2032: Visiongain Reports Ltd - Yahoo Finance - August 5th, 2022
- I Got Critiqued by YouTuber Gutsick Gibbon - Discovery Institute - August 5th, 2022
- CRISPR Technology in the Agricultural Industry: Patent and Regulatory Updates - JD Supra - August 5th, 2022